Thursday, February 10, 2022 1:51:56 PM
New York Yankees and Duke Basketball
Recent XLO News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 08:16:28 PM
- Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference • GlobeNewswire Inc. • 08/28/2024 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:51:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:45:15 AM
- Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 12:00:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:30:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:06:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:15:17 PM
- Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors • GlobeNewswire Inc. • 06/13/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:09:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:45:14 AM
- Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/07/2024 04:15:40 AM
- Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
- Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing • GlobeNewswire Inc. • 03/28/2024 11:05:00 AM
- Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program • Business Wire • 03/28/2024 11:00:00 AM
- Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program • GlobeNewswire Inc. • 03/28/2024 11:00:00 AM
- Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/28/2024 09:01:00 PM
- Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference • GlobeNewswire Inc. • 01/31/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:30:28 PM
- Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapies • GlobeNewswire Inc. • 01/08/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:38:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:15:28 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM